Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid | Synapse

April 9, 2025

View Full Paper

Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid

HKHiroshi KogaKurume University MTMasahiro TsutsumiKurume University KTKwesi TeyeKurume University

Key Points

Key points are not available for this paper at this time.

Abstract

This case report describes a patient with immune checkpoint inhibitor–associated bullous pemphigoid and preexisting anti-BP180–C-terminus antibodies.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Koga et al. (Wed,) studied this question.

synapsesocial.com/papers/6a22d129887b2d65ce604d76 https://doi.org/https://doi.org/10.1001/jamadermatol.2024.6665

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid2016 · 46 citations
2Pemphigoid diseases2012 · 994 citations
3BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors2019 · 102 citations
4Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis2019 · 42 citations
5Hemidesmosomal Reactivity and Treatment Recommendations in Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid—A Retrospective, Monocentric Study2022 · 14 citations